Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAP3K11 |
| Upstream (Parents) |
|---|
| (<<) AVP → MAP3K11 |
| (<<) BMPR2 → MAP3K11 |
| (<<) CSNK1A1 → MAP3K11 |
| (<<) DUSP2 → MAP3K11 |
| (<<) EFHD2 → MAP3K11 |
| (<<) JUND → MAP3K11 |
| (<<) LOC92249 → MAP3K11 |
| (<<) MAP3K3 → MAP3K11 |
| (<<) MAP3K7 → MAP3K11 |
| (<<) MAPKAPK5 → MAP3K11 |
| (<<) PARP10 → MAP3K11 |
| (<<) PPP2R5B → MAP3K11 |
| (<<) PRKCSH → MAP3K11 |
| (<<) PRPF4B → MAP3K11 |
| (<<) RAVER1 → MAP3K11 |
| (<<) RPS6KA4 → MAP3K11 |
| (<<) VEGFB → MAP3K11 |
| (<<) ZNF205 → MAP3K11 |
| Downstream (Children) |
|---|
| MAP3K11 → ALK (>>) |
| MAP3K11 → BAD (>>) |
| MAP3K11 → BCL3 (>>) |
| MAP3K11 → CAMKK1 (>>) |
| MAP3K11 → CARD9 (>>) |
| MAP3K11 → CDC42EP1 (>>) |
| MAP3K11 → CDC42EP2 (>>) |
| MAP3K11 → CYP4F2 (>>) |
| MAP3K11 → EHD1 (>>) |
| MAP3K11 → FADS2 (>>) |
| MAP3K11 → FAM100B (>>) |
| MAP3K11 → FCRLB (>>) |
| MAP3K11 → GNG5 (>>) |
| MAP3K11 → INPPL1 (>>) |
| MAP3K11 → IQSEC2 (>>) |
| MAP3K11 → KIAA1949 (>>) |
| MAP3K11 → MMP25 (>>) |
| MAP3K11 → MOBKL2C (>>) |
| MAP3K11 → NOTCH4 (>>) |
| MAP3K11 → NRN1 (>>) |
| MAP3K11 → PLEKHF1 (>>) |
| MAP3K11 → PRKACA (>>) |
| MAP3K11 → PROCA1 (>>) |
| MAP3K11 → RHOG (>>) |
| MAP3K11 → RPS6KB2 (>>) |
| MAP3K11 → RRP15 (>>) |
| MAP3K11 → RXRA (>>) |
| MAP3K11 → SGSH (>>) |
| MAP3K11 → STAT6 (>>) |
| MAP3K11 → STK40 (>>) |
| MAP3K11 → SULF2 (>>) |
| MAP3K11 → TRAF2 (>>) |
